Clinical trial
Observational Study of Long-term Safety and Efficacy of Subjects Who Participated in CS10BR05 Inj. Phase 1 Study
NCT04495582 is registered in ClinicalTrials.gov with Corestemchemon, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study of Long-term Safety and Efficacy of Subjects Who Participated in CS10BR05 Inj. Phase 1 Study
- Lead sponsor
- Corestemchemon, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 28, 2018
- Completion date
- September 25, 2024
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.